Multiple-Drug Resistant Enterococci: The Nature of the Problem and an Agenda for the Future

by Mark M. Huycke, Daniel F. Sahm, Michael S. Gilmore
Published 1998-06-01

Factors Influencing Fluoroquinolone Resistance

by Daniel F. Sahm, Clyde Thornsberry, Mark E. Jones, James A. Karlowsky
Published 2003-12-01

In Vitro Activity of Iclaprim against Methicillin-Resistant Staphylococcus aureus Nonsusceptible to Daptomycin, Linezolid, or Vancomycin: A Pilot Study

by David B. Huang, Stephen Hawser, Curtis G. Gemmell, Daniel F. Sahm
Published 2017-01-01

Activity of ceftolozane/tazobactam against Gram-negative isolates from patients with lower respiratory tract infections – SMART United States 2018–2019

by James A. Karlowsky, Sibylle H. Lob, Katherine Young, Mary R. Motyl, Daniel F. Sahm
Published 2021-03-01

Activity of ceftolozane–tazobactam and comparators against Pseudomonas aeruginosa from patients in different risk strata – SMART United States 2016–2017

by Sibylle H. Lob, Daryl J. Hoban, Katherine Young, Mary R. Motyl, Daniel F. Sahm
Published 2020-03-01

Resistance among Gram-negative ESKAPE pathogens isolated from hospitalized patients with intra-abdominal and urinary tract infections in Latin American countries: SMART 2013–2015

by James A. Karlowsky, Daryl J. Hoban, Meredith A. Hackel, Sibylle H. Lob, Daniel F. Sahm
Published 2017-05-01

Prevalence of mcr-type genes among colistin-resistant Enterobacteriaceae collected in 2014-2016 as part of the INFORM global surveillance program.

by Mark G Wise, Mark A Estabrook, Daniel F Sahm, Gregory G Stone, Krystyna M Kazmierczak
Published 2018-01-01

Molecular characterization of clinical isolates of Enterobacterales with elevated MIC values for aztreonam-avibactam from the INFORM global surveillance study, 2012–2017

by Mark Estabrook, Krystyna M. Kazmierczak, Mark Wise, Francis F. Arhin, Gregory G. Stone, Daniel F. Sahm
Published 2021-03-01

In vitro activity of imipenem/relebactam against Enterobacteriaceae and Pseudomonas aeruginosa isolated from intraabdominal and urinary tract infection samples: SMART Surveillance...

by James A. Karlowsky, Sibylle H. Lob, Krystyna M. Kazmierczak, Katherine Young, Mary R. Motyl, Daniel F. Sahm
Published 2020-06-01

Reduced susceptibility mechanism to cefiderocol, a siderophore cephalosporin, among clinical isolates from a global surveillance programme (SIDERO-WT-2014)

by Naoki Kohira, Meredith A. Hackel, Yoshino Ishioka, Miho Kuroiwa, Daniel F. Sahm, Takafumi Sato, Hideki Maki, Yoshinori Yamano
Published 2020-09-01

In vitro activity of ceftaroline against bacterial pathogens isolated from patients with skin and soft tissue and respiratory tract infections in the Middle East and Africa: AWARE...

by James A. Karlowsky, Meredith A. Hackel, Samue l K. Bouchillon, Warren Lowman, Ramy El Mahdy Kotb, Naglaa Mohamed, Gregory G. Stone, Daniel F. Sahm
Published 2021-03-01

Antimicrobial resistance in respiratory pathogens isolated in Brazil during 1999-2000

by Ian A. Critchley, Renée S. Blosser, James A. Karlowsky, Juri Yamakita, Alfonso Barth, Helio S. Sader, Caio Mendes, Lucia Teixeira, Flavia Rossi, Cicero A. C. Dias, Mark E. Jones, Clyde Thornsberry, Daniel F. Sahm

In vitro studies evaluating the activity of imipenem in combination with relebactam against Pseudomonas aeruginosa

by Katherine Young, Ronald E. Painter, Susan L. Raghoobar, Nichelle N. Hairston, Fred Racine, Douglas Wisniewski, Carl J. Balibar, Artjohn Villafania, Rumin Zhang, Daniel F. Sahm, Timothy Blizzard, Nicholas Murgolo, Milton L. Hammond, Mary R. Motyl
Published 2019-07-01